ICAM1 and cancer: Under physiological conditions, ICAM-1 is expressed at low levels on the surface of endothelial cells, epithelial cells, and some immune cells, and in inflammatory diseases, such as cancer, it is overexpressed, revealing to be a potential biomarker for early GC diagnosis and prognosis, suggesting its role in precision surgery for the patients [75].